Viking Therapeutics (VKTX) earnings, Jul 29, 2026: EPS −90%, stock −1.0%
In brief
Viking Therapeutics reported on Jul 29, 2026. Earnings per share changed −90% year over year, 10.8% above the estimate; revenue 0%. The stock opened with a +0.3% gap and closed the day −1.0% (Jul 30, 2026). The stock is now 40.2% below its 52-week high, −29.3% over 12 months. Next report: Feb 10, 2027.
EPS vs estimate+10.8%
EPS, YoY−90%
Revenue, YoY0%
Gap · day+0.3% · −1.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 29, 2026 | +0.3% | −1.0% |
Next-quarter estimates, ratings and the VKTX chart are in the terminal.
Open the terminalFAQ
When is Viking Therapeutics's next earnings report?
Feb 10, 2027. The date comes from daily data and is corrected if the company moves it.
How did Viking Therapeutics stock react to the report?
Opening gap +0.3%, day's result −1.0%.
Did Viking Therapeutics's earnings grow?
Earnings per share fell 90% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.